About: ESTABLISHMENT OF A SAFETY PROTOCOL FOR THE ADMINISTRATION OF TREATMENTS IN MULTIPLE SCLEROSIS DURING THE SARS-CoV-2 PANDEMIC

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: ESTABLISHMENT OF A SAFETY PROTOCOL FOR THE ADMINISTRATION OF TREATMENTS IN MULTIPLE SCLEROSIS DURING THE SARS-CoV-2 PANDEMIC Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	ESTABLISHMENT OF A SAFETY PROTOCOL FOR THE ADMINISTRATION OF TREATMENTS IN MULTIPLE SCLEROSIS DURING THE SARS-CoV-2 PANDEMIC
Creator	Aguirre, Clara Alarcon, Teresa Cardeñoso, Laura Del Río, Beatriz Figuerola-Tejerina, Angels Meca-Lallana, Virginia Ruizálvarez, Miguel Vivancos, José
Source	Elsevier; Medline; PMC
abstract	covid:8092e3b9022d2ac3c0da17cd01403ee3054cc9ba#abstract
has issue date	2020-06-02(xsd:dateTime)
bibo:doi	10.1016/j.msard.2020.102244
bibo:pmid	32544863
has license	no-cc
sha1sum (hex)	8092e3b9022d2ac3c0da17cd01403ee3054cc9ba
schema:url	https://doi.org/10.1016/j.msard.2020.102244
resource representing a document's title	ESTABLISHMENT OF A SAFETY PROTOCOL FOR THE ADMINISTRATION OF TREATMENTS IN MULTIPLE SCLEROSIS DURING THE SARS-CoV-2 PANDEMIC
has PubMed Central identifier	PMC7264931
has PubMed identifier	32544863
schema:publication	Mult Scler Relat Disord
resource representing a document's body	covid:8092e3b9022d2ac3c0da17cd01403ee3054cc9ba#body_text
is schema:about of	named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'asymptomatic infections' named entity 'fingolimod' named entity 'COVID-19' named entity 'rapid tests' named entity 'serology' named entity 'serology' named entity 'IgM' named entity 'IgG' named entity 'incubation period' named entity 'window period' named entity 'ocrelizumab' named entity 'thrombosis' named entity 'infection' named entity 'sensitivity and specificity' named entity 'immunosuppression' named entity 'methyl prednisolone' named entity 'virus' named entity 'IgM' named entity 'cytokine release syndrome' named entity 'comorbidities' named entity 'inflammatory state' named entity 'infection' named entity 'window period' named entity 'lymphopenia' named entity 'antibodies' named entity 'PCR' named entity 'infection' named entity 'Immunosuppressive' named entity 'IgG' named entity 'IgM' named entity 'infection' named entity 'cladribine' named entity 'steroids' named entity 'immunosuppressive drugs' named entity 'risk factors' named entity 'disease-modifying' named entity 'immunosuppressive' named entity 'exudate' named entity 'SARS-CoV-2' named entity 'COVID-19' named entity 'acute infection' named entity 'viral protein' named entity 'nasopharyngeal swabs' named entity 'disability' named entity 'PCR' named entity 'antigens' named entity 'alemtuzumab' named entity 'make decisions' named entity 'IgM' named entity 'virus' named entity 'immunosuppression' named entity 'higher risk' named entity 'Injectables' named entity 'viral RNA' named entity 'clinical symptoms' named entity 'rituximab' named entity 'SARS-CoV-2' named entity 'virus' named entity 'dimethyl fumarate' named entity 'diagnostic accuracy' named entity 'Corticosteroids' named entity 'relapse' named entity 'immunosuppressive' named entity 'PCR' named entity 'immune response' named entity 'COVID' named entity 'teriflunomide' named entity 'infection' named entity 'infection' named entity 'immunosuppressive treatment' named entity 'RT-PCR' named entity 'IgM'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software